Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings

Shares (Q2 2026)
3,520
Value
$1.11M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of LGND by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,520$1.11M<0.1%−390−10.0%ReducedHolders
Q1 20263,910$780.6K<0.1%−730−15.7%ReducedHolders
Q4 20254,640$877.3K<0.1%+339+7.9%AddedHolders
Q3 20254,301$761.9K<0.1%−680−13.7%ReducedHolders
Q2 20254,981$566.2K<0.1%−124−2.4%ReducedHolders
Q1 20255,105$536.7K<0.1%−1,039−16.9%ReducedHolders
Q4 20246,144$658.3K<0.1%+1,490+32.0%AddedHolders
Q3 20244,654$465.8K<0.1%+951+25.7%AddedHolders
Q2 20243,703$312.0K<0.1%−924−20.0%ReducedHolders
Q1 20244,627$338.2K<0.1%+363+8.5%AddedHolders
Q4 20234,264$304.5K<0.1%+599+16.3%AddedHolders
Q3 20233,665$219.6K<0.1%−49−1.3%ReducedHolders
Q2 20233,714$267.8K<0.1%+312+9.2%AddedHolders
Q1 20233,402$250.3K<0.1%−409−10.7%ReducedHolders
Q4 20223,811$254.6K<0.1%+284+8.1%AddedHolders
Q3 20223,527$304.0K<0.1%+30+0.9%AddedHolders
Q2 20223,497$311.0K<0.1%−1,657−32.1%ReducedHolders
Q1 20225,154$580.0K<0.1%−1,019−16.5%ReducedHolders
Q4 20216,173$953.0K<0.1%+245+4.1%AddedHolders
Q3 20215,928$826.0K<0.1%−2,233−27.4%ReducedHolders
Q2 20218,161$1.07M<0.1%+731+9.8%AddedHolders
Q1 20217,430$1.13M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.